| Literature DB >> 22217360 |
Eilish M Lynch1, Mark McGee, Sean Doyle, Bernadette Earley.
Abstract
BACKGROUND: The effect of pre-weaning concentrate supplementation on peripheral distribution of leukocytes, functional activity of neutrophils, acute phase protein response, metabolic and behavioural response, and performance of abruptly weaned and housed beef calves was investigated. Calves were grazed with their dams until the end of the grazing season when they were weaned and housed (day (d) 0) in a concrete slatted floor shed, and offered grass silage ad libitum plus supplementary concentrates. Twenty-six days prior to weaning and housing, 20 singled suckled, pure-bred Simmental male (non-castrated), (n = 10, m) and female (n = 10, f) calves were assigned to one of two treatments (i) concentrate supplement (CS: n = 10 (5 m and 5 f), mean age (s.d.) 201 (12.8) d, mean weight (s.d.) 258 (20.2) kg) or (ii) no concentrate supplement (controls) (NCS: n = 10, (5 m and 5 f), mean age (s.d.) 201 (13.4) d, mean weight (s.d.) 257 (19.6) kg) pre-weaning.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22217360 PMCID: PMC3286413 DOI: 10.1186/1746-6148-8-1
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Figure 1Experimental design and sample collection schedule for beef calves that were supplemented with concentrates for 26 d prior to abrupt weaning (d 0) and subsequently offered grass silage plus concentrates at housing. * denotes additional blood collection time-points for haematological analysis and rectal body temperature recordings. Concentrate supplemented (CS) calves were offered concentrates for 26 d prior to weaning, whereas non supplemented (NCS) calves were not offered concentrates during the pre-weaning period (d -26 to d 0). On d 0, all calves were abruptly weaned, housed and offered grass silage ad libitium plus concentrates.
Antibodies used in the immunostaining of leukocyte surface markers
| CD4 | T-helper/inducer cells | CC8 | IgG2a | 7 μL/mL | Serotec |
| CD8 | T-cytotoxic/suppressor cells | CC63 | IgG2a | 7 μL/mL | Serotec |
| WC1 | Subset of γδ T cells | CC15 | IgG2a | 7 μL/mL | Serotec |
| MHC class II | Antigen presenting cells (B cells, activated T cells) | H42A | IgG2a | 7 μL/mL | VMRD |
| CD62L | L-selectin | BAQ92A | IgG1 | 14 μL/mL | VMRD |
| G1 | Neutrophils (and eosinophils) | MM20A | IgG1 | 14 μL/mL | VMRD |
| CD45 | All leukocytes (pan marker)2 | CC1 | IgG1 | 3.5 μL/mL | Serotec |
| IgG1 isotype | Mouse IgG1a negative control | - | - | 7 μL/mL | Serotec |
| IgG2a isotype | Mouse IgG2a negative control | - | - | 7 μL/mL | Serotec |
1Serotec (Oxford, UK), VMRD (Pullman, WA, USA).
2Used to differentiate leukocyte populations and exclude debris (gate analysis).
Effect of concentrate supplementation for 26 days pre-weaning on rectal body temperature in abruptly weaned and housed beef calves
| Rectal body temperature, °C | CS | 38.3a | 39.0b | 38.7b | 38.5a | 38.6a | 38.4a | 0.11 | ** | ** | NS |
| NCS | 38.5a | 39.1b | 38.9b | 38.6a | 38.6a | 38.6a | |||||
T = treatment, S = sampling time, T × S = treatment × sampling time interaction.
CS = concentrate supplement prior to abrupt weaning (n = 10).
NCS = no concentrate supplement prior to abrupt weaning (n = 10).
1Levels of significance: NS = P > 0.05, ** = P < 0.01. a, bWithin a row, least squares means without a common superscript differ (P <0.05).
Effect of concentrate supplementation for 26 days pre-weaning on total leukocyte and differential populations in abruptly weaned and housed beef calves
| CS | 10.5 | 11.3 | 10.4 | 10.1 | 10.0 | 9.3 | 0.52 | NS | NS | NS | |
| NCS | 10.3 | 10.7 | 9.6 | 9.9 | 9.8 | 10.0 | |||||
| CS | 2.5a | 4.2b | 3.7b | 2.5a | 2.8a | 2.3a | 0.31 | NS | *** | NS | |
| NCS | 2.6a | 4.8b | 3.9c | 2.7a | 2.7a | 2.7a | |||||
| CS | 7.3a | 5.2b | 5.3b | 6.6a | 6.7a | 6.6a | 0.33 | NS | ** | NS | |
| NCS | 6.7a | 4.9b | 5.0b | 6.0a | 7.1a | 6.4a | |||||
| CS | 0.68a | 0.61ab | 0.58ab | 0.61ab | 0.63ab | 0.37b | 0.063 | NS | ** | NS | |
| NCS | 0.73 | 0.69 | 0.70 | 0.73 | 0.82 | 0.51 | |||||
| CS | 0.21 | 0.26 | 0.21 | 0.17 | 0.10 | 0.16 | 0.048 | NS | NS | NS | |
| NCS | 0.22 | 0.20 | 0.24 | 0.26 | 0.15 | 0.19 | |||||
| CS | 0.09 | 0.11 | 0.12 | 0.11 | 0.08 | 0.13 | 0.029 | NS | NS | NS | |
| NCS | 0.11 | 0.10 | 0.09 | 0.09 | 0.08 | 0.10 | |||||
T = treatment, S = sampling time, T × S = treatment × sampling time interaction.
CS = concentrate supplement prior to abrupt weaning (n = 10). NCS = no concentrate supplement prior to abrupt weaning (n = 10).
1Levels of significance: NS = P > 0.05, ** = P < 0.01, *** P < 0.001. a, b, cWithin a row, least squares means without a common superscript differ (P <0.05).
Effect of concentrate supplementation for 26 d pre-weaning on neutrophil surface expression of CD62L, and neutrophil phagocytic and oxidative burst activity in abruptly weaned and housed beef calves
| CS | 35.2a | 20.19b | 35.6a | 35.2a | 2.24 | NS | * | NS | |
| NCS | 36.2a | 17.3b | 36.0a | 34.0a | |||||
| CS | 81.1a | 71.2b | 78.0a | 83.2a | 1.99 | NS | * | NS | |
| NCS | 80.5a | 73.2b | 74.8a | 80.0a | |||||
| CS | 12.9 | 10.7 | 16.8 | 14.3 | 0.97 | NS | NS | NS | |
| NCS | 14.7 | 12.9 | 14.8 | 13.01 | |||||
| CS | 26.0 | 29.4 | 33.1 | 27.3 | 2.34 | NS | NS | NS | |
| NCS | 24.2 | 23.9 | 26.4 | 25.0 | |||||
| CS | 13.0 | 10.7 | 16.8 | 14.3 | 0.71 | NS | NS | NS | |
| NCS | 14.8 | 12.9 | 14.8 | 13.0 | |||||
T = treatment, S = sampling time, T × S = treatment × sampling time interaction.
CS = concentrate supplement prior to abrupt weaning (n = 10). NCS = no concentrate supplement prior to abrupt weaning (n = 10).
1Levels of significance: NS = P > 0.05, * = P < 0.05, ** = P < 0.01, *** = P < 0.001. a, b, cWithin a row, least squares means without a common superscript differ (P <0.05).
2CD62L = L-selectin marker.
3Mean fluorescence intensity = MFI.
Figure 2Effect of concentrate supplementation for 26 d pre-weaning on percentage CD4. CS = concentrate supplement prior to abrupt weaning (n = 10), NCS = no concentrate supplement prior to abrupt weaning (n = 10). a, b, cBetween days, least squares means without a common superscript differ (P <0.05). x, yWithin a day, least squares means without a common superscript differ (P <0.01).
Figure 3Effect of concentrate supplementation for 26 d pre-weaning on percentage (a) WC1. CS = concentrate supplement prior to abrupt weaning (n = 10). NCS = no concentrate supplement prior to abrupt weaning (n = 10). a, b,Between days, least squares means without a common superscript differ (P <0.001). x, yWithin a day, least squares means without a common superscript differ (P <0.001). There was a significant treatment × sampling time interaction for percentage WC1+ lymphocytes.
Effect of concentrate supplementation pre-weaning on concentration of plasma fibrinogen and haptoglobin in abruptly weaned and housed beef calves
| 0.38a | 0.62b | 0.48ab | 0.47ab | 0.068 | NS | * | NS | ||
| 0.35a | 0.80b | 0.67ab | 0.42ab | ||||||
| 379 | 456 | 495 | 432 | 24.9 | NS | NS | NS | ||
| 439 | 524 | 545 | 486 | ||||||
T = treatment, S = sampling time, T × S = treatment × sampling time interaction.
1Levels of significance: NS = P > 0.05. * = P < 0.05. a, bWithin a row, least squares means without a common superscript differ (P <0.05).
2PHA = Phytohaemagglutinin.
3ConA = Concanavalin A.
CS = concentrate supplement prior to abrupt weaning (n = 10). NCS = no concentrate supplement prior to abrupt weaning (n = 10).
Effect of concentrate supplementation for 26 d pre-weaning on plasma metabolites in abruptly weaned and housed beef calves
| CS | 70.3a | 73.9b, x | 72.8a | 70.6a | 0.98 | * | † | NS | |
| NCS | 68.3a | 70.9b.y | 72.0b | 67.6a | |||||
| CS | 34.0a | 33.9a | 35.4a | 31.6b | 0.45 | † | * | NS | |
| NCS | 33.2a | 33.4a | 33.4a | 31.0b | |||||
| CS | 36.6a | 38.9b, x | 37.7a | 38.9b | 0.80 | NS | ** | * | |
| NCS | 35.1a | 37.6b, y | 38.4b | 36.6a | |||||
| CS | 295 | 304 | 359 | 317 | 42.7 | NS | NS | NS | |
| NCS | 307 | 297 | 324 | 350 | |||||
| CS | 4.2a | 3.1b | 3.1b | 2.5c | 0.17 | NS | *** | NS | |
| NCS | 4.3a | 3.3b | 3.0b | 2.5c | |||||
| CS | 4.5 | 4.6 | 4.3 | 4.3 | 0.08 | NS | NS | NS | |
| NCS | 4.5 | 4.8 | 4.3 | 4.3 | |||||
| CS | 0.19a | 0.27b | 0.25a | 0.30b | 0.014 | NS | * | NS | |
| NCS | 0.17a | 0.24b | 0.23a | 0.28c | |||||
| CS | 0.17 | 0.24 | 0.17 | 0.13 | 0.023 | NS | * | NS | |
| NCS | 0.13a | 0.33b | 0.20ab | 0.09a | |||||
1Levels of significance: NS = P > 0.05, † = P = 0.06, * = P < 0.05, ** = P < 0.01, *** = P < 0.001. a, b, cWithin a row, least squares means without a common superscript differ (P <0.05). x, yWithin a column (day) for each variable, least squares means without a common superscript differ (P <0.05). T = treatment, S = sampling time, T × S = treatment × sampling time interaction. 2βHB = β-hydroxybutyrate, 3NEFA = non-esterified fatty acids.
CS = concentrate supplement prior to abrupt weaning (n = 10), NCS = no concentrate supplement prior to abrupt weaning (n = 10).